image credit- shutterstock
Quadria Group, Asia’s leading healthcare-focused private equity platform, has announced the launch of HealthQuad Fund III, with a proposed raise of up to $300 million (target corpus of $200 million with a $100 million greenshoe option).
As a successor to Funds I and II, the third fund seeks to build on a proven track record of identifying and scaling pioneering healthcare ventures that have significantly expanded access, affordability, and quality of care across India.
The launch is part of Quadria’s long-term vision to build India’s most integrated healthcare investment platform, offering capital solutions from early-stage innovation to scaled growth across the healthcare value chain.
Incubated in 2016, HealthQuad was a pioneering initiative by the Quadria Group to create a distinct investment vehicle, separate from its flagship fund, focused on backing disruptive, tech-enabled healthcare models at the early-growth stage. Funds I and II backed over 18 companies including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences, many of which have gone on to become category leaders.
With Fund III, the Quadria Group takes a decisive step toward building India’s largest and most influential healthcare investment franchise. As part of this next chapter, Quadria group, through Dr. Amit Varma, Abrar Mir and Sunil Thakur will assume full ownership and control of the platform following its separation from KOIS. Quadria group has retained a large part of existing investment and investment committee team members who will continue to be involved in the existing portfolio investments.
Further, Quadria group will be strengthening the team through addition of seasoned investing, operating and clinical team that will be shortly announced.
Through this new fund, Quadria Group intends to combine its pan-Asian network, institutional investor base, and operational expertise to deliver scaled impact and value. The Group recently closed Quadria Capital Fund III at $1.07 billion, with strong backing from leading global institutions.
